Table 1.
Embryoid body (EB) vs monolayer (ML) |
Factors tested |
Additional conditions (eg bioreactor) |
Assays (mineral deposition, gene expression, implant) |
Reference |
---|---|---|---|---|
Mouse | ||||
EB | AA, βGP, dex |
|
(5) | |
EB | AA, βGP, RA, BMP2 |
|
(70) | |
EB | AA, βGP, VD3 |
|
(22) | |
EB | AA, βGP, dex |
|
(20) | |
EB | AA, βGP, VD3, RA, BMP2 |
|
(23) | |
ESCs seeded on scaffold to form cartilage matrix |
|
(25) | ||
EB | AA, βGP, dex | Decellularized osteogenic extracellular matrix |
|
(26) |
ML | AA, βGP, dex | CultiSpher S microcarrier |
|
(29) |
EB | AA, βGP, dex |
|
(88) | |
EB | AA, βGP, VD3 | 3D type I collagen gel |
|
(30) |
EB | AA, βGP, dex, PPARγ inhibitor, RA |
|
(89) | |
EB | AA, βGP, VD3 | Cyclic loading |
|
(32) |
EB | AA, βGP, dex, BMP4 |
|
(21) | |
Human | ||||
EB | AA, βGP, dex |
|
(18) | |
EB | AA, βGP, dex |
|
(19) | |
ML | Various | HA/TCP particles or carpet |
|
(31) |
EB | Lentiviral expression of Runx2 and BMP-2- enriched hydrogel |
|
(90) | |
ML | AA, βGP, dex | Decellularized bone scaffolds and perfused bioreactor culture |
|
(27) |
ML | AA, βGP, dex | Mechanical strain on BioFlex plates |
|
(33) |
ML | AA, βGP | Decellularized osteogenic matrix on PLGA scaffold |
|
(28) |
ML | Zinc finger nuclease targeting of Col2.3GFP and hydroxyapatite /collagen matrix scaffold |
|
(24) |
Abbreviations: AA – ascorbic acid; βGP – β-glycerophosphate; RA – retinoic acid; VD3 – 1,25OH-vitamin D3; PDLLA – poly-D, L-lactide; ALP – alkaline phosphatase; BMSC – bone marrow stromal cell; PLGA – poly(lactic-co-glycolic acid); HA/TCP – hydroxyapatite/tricalcium phosphate